The Lupus Forum

The Lupus Forum

Welcome to the Lupus Forum. The Lupus Forum is an educational website developed under the auspices of the University of Leeds and is dedicated to the dissemination of the latest developments in the field of lupus. It provides continuing medical education to clinicians around the globe to facilitate greater understanding of lupus, its treatments, and clinical practice.

Be sure to visit the podcast's website and support the creator: soundcloud.com

Author

The Lupus Forum

Category

Education

Podcast website

soundcloud.com

Latest episode

Nov 11, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

EULAR 2024 Highlights: Day 4 14.06.2025

Join Professor Ed Vital as he summarises his top abstracts, posters, and presentations from Day 4 of EULAR 2025 (Saturday, June 14).

EULAR 2025 Highlights: Day 3 13.06.2025

Join Professor Ed Vital as he summarises his top abstracts, posters, and presentations from Day 3 of EULAR 2025 (Friday, June 13).

Discussing Lupus: Insights into belimumab and anifrolumab in SLE 12.06.2025

Our Steering Committee Member Professor Maria Dall’Era is joined by Professor Vibeke Strand in the latest Lupus Forum podcast. Together they discuss the efficacy of belimumab treatment in patients with SLE. They will also discuss the impact of long-term anifrolumab treatment on patients’ perceived health status and health-related quality of life. If you are interested in the papers discussed, head...

EULAR 2025 Highlights: Day 2 12.06.2025

Join Professor Ed Vital as he summarises his top abstracts, posters, and presentations from Day 2 of EULAR 2025 (Thursday, June 12).

EULAR 2025 Highlights: Day 1 11.06.2025

EULAR 2025 Highlights: Day 1 by The Lupus Forum

EULAR 2025 Preview Podcast 09.06.2025

Join Professors Ed Vital and Chris Edwards as they preview what they are most looking forward to this EULAR, introducing some of the top abstracts and posters we’ve chosen so that you can better plan your time at what will be a busy and exciting congress.

JAKi in the treatment of SLE 06.06.2025

Join Professors Ed Vital, Cynthia Aranow, Richard Furie, and Chris Edwards as they discuss the role of the JAK-STAT pathway, the emerging evidence of using JAK Inhibitors in clinical trials (SLEek trial), and the need for long-term data and the challenges faced.

Advances in Lupus Nephritis Podcast 23.05.2025

Join Professors Liz Lightstone and Maria Dall’Era for an expert-led discussion focused on lupus nephritis, exploring its current standard of care, practical implementation in clinical settings, and evolving treatment landscape. This podcast will delve into the latest advances in the management of lupus nephritis, including emerging therapies such as obinutuzumab, and examine the future treatment p...

Advances in Lupus Nephritis 19.05.2025

Join Professors Ed Vital, Brad Rovin, Liz Lightstone, and Maria Dall'Era as they review the current standard of care, the recommended guidelines, and emerging therapies in lupus nephritis. With discussions outlining strategies to improve real-world challenges in the management and overall quality of life for these patients.

Discussing Lupus: Insights into belimumab and telitacicept in SLE 15.05.2025

Discussing Lupus: Insights into belimumab and telitacicept in SLE by The Lupus Forum

Discussing Lupus: Belimumab in mucocutaneous lupus erythematosus and anifrolumab in SLE 17.04.2025

Our Steering Committee experts Professor Victoria Werth and Chris Edwards join the latest Lupus Forum podcast to discuss the effect of belimumab vs placebo on mucocutaneous manifestations of SLE, and the long-term impact of anifrolumab vs placebo on LLDAS and DORIS attainment in patients with SLE. If you are interested in the papers discussed, head on over to the Lupus Forum today! Download our la...

Advances in SLE: Highlights Podcast 15.04.2025

Advances in SLE: Highlights Podcast by The Lupus Forum

Discussing Lupus: Belimumab vs telitacicept post-rituximab, efficacy & safety of obinutuzumab in LN 14.03.2025

Discussing Lupus: Belimumab vs telitacicept post-rituximab, efficacy & safety of obinutuzumab in LN by The Lupus Forum

Challenges in Lupus Nephritis Highlights Podcast 04.03.2025

Challenges in Lupus Nephritis Highlights Podcast by The Lupus Forum

Discussing Lupus: LLDAS and remission in HDAS SLE patients and the 2024 APLAR consensus for LN 30.01.2025

Professor Vibeke Stand (Stanford University) and Professor Eric Morand (Monash University) join the latest Lupus Forum podcast to discuss LLDAS and remission in SLE patients with HDAS, as well as the latest APLAR treatment consensus for LN.. If you are interested in the papers discussed, head on over to the Lupus Forum today! Download our latest slide decks and stay up to date with our monthly pod...

Discussing Lupus: Voclosporin immunosuppressive therapy and new ACR guidelines for lupus nephritis 23.12.2024

Steering Committee member Professor Maria Dall’Era, Professor of Medicine and Chief of the Division of Rheumatology at the of University of California, San Francisco, USA, is joined by fellow member Professor Brad Rovin, who is Lee A. Hebert Professor of Nephrology and Medical Director at Ohio State University Clinical Research Management Institute, Columbus, Ohio, on the latest Lupus Forum podcas...

Lupus at ACR 2024: Review Podcast 28.11.2024

Lupus at ACR 2024: Review Podcast by The Lupus Forum

Discussing Lupus: Efficacy and safety results of iberdomide in CLE, and SGLT2i vs. DPP4i in both SLE and comorbid type 2 diabetes 28.11.2024

Steering Committee member Professor Victoria Werth, who is Chief of the Division of Dermatology at the Philadelphia Veterans Administration Hospital, Pennsylvania, USA, is joined by fellow member Professor Chi-Chiu Mok, who is Chief of the Division of Rheumatology, Department of Medicine, Tuen Mun Hospital, Hong Kong, on the latest Lupus Forum podcast. Together, they discuss the efficacy and safet...

Lupus at ACR 2024: Preview Podcast 12.11.2024

Lupus at ACR 2024: Preview Podcast by The Lupus Forum

ACR 2024 Highlights: Day 1 11.11.2024

ACR 2024 Highlights: Day 1 by The Lupus Forum

ACR 2024 Highlights: Day 2 11.11.2024

ACR 2024 Highlights: Day 2 by The Lupus Forum

ACR 2024 Highlights: Day 3 11.11.2024

ACR 2024 Highlights: Day 3 by The Lupus Forum

Discussing Lupus: Defining ANA-associated arthritis and achieving treatment targets 31.10.2024

Steering Committee members Professor Ed Vital, who is a Professor in Autoimmune Connective Tissue Diseases and Honorary Consultant Rheumatologist, at Leeds Teaching Hospitals NHS Trust, UK, is joined by Professor Richard Furie, who is Chief of the Division of Rheumatology at the Department of Medicine, Northwell Health, New York, and Professor of Medicine at the Zucker School of Medicine at Hofstr...

Discussing Lupus: Sequential belimumab and rituximab treatment and CAR T-cell therapy 26.09.2024

Steering Committee members Professor Chris Edwards from the University Hospital Southampton NHS Foundation Trust is joined by Professor Victoria Werth, from the Philadelphia Veterans Administration Hospital, Pennsylvania, USA on the latest Lupus Forum podcast. Together, they discuss the efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients wit...

Rising to the challenge of inequity of outcomes in lupus treatment 18.09.2024

Join Professors Ed Vital, Vibeke Strand, Laurent Arnaud, and Guillermo Pons-Estel as they unpack the key challenges of inequities of outcomes in lupus treatment. Providing an overview of social determinants of health in SLE, the impact of race and ancestry, and controlling disease in low and middle income country populations. You can view this video on our website here: https://lupus-forum.com/exp...

Listen to the The Lupus Forum podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.